Exenatide as a novel weight loss modality in patients without diabetes.

The Annals of pharmacotherapy

Volumn 46, Issue 12, 2012, Pages 1700-1706

  Moreno, Jessica L ^a   Willett, Kristine C ^b   Desilets, Alicia R ^b  

^a Massachusetts College of Pharmacy and Health Sciences ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; EXENDIN 4; PEPTIDE; VENOM;

ADULT; BODY WEIGHT; CLINICAL TRIAL (TOPIC); DRUG EFFECT; HUMAN; OBESITY; REVIEW; WEIGHT REDUCTION;

ADULT; ANTI-OBESITY AGENTS; BODY WEIGHT; CLINICAL TRIALS AS TOPIC; HUMANS; OBESITY; OVERWEIGHT; PEPTIDES; VENOMS; WEIGHT LOSS;

EID: 84878258051     PISSN: None     EISSN: 15426270     Source Type: Journal    
DOI: 10.1345/aph.1R372     Document Type: Review

References (0)